Serological characteristics of ABO blood group and molecular genetic analysis of a Chinese pedigree with cisAB09 subtype.
10.3760/cma.j.cn511374-20220725-00490
- Author:
Yuanyuan WANG
1
;
Fangnian YANG
;
Yuqing SHEN
;
Yusong GUO
;
Bo JIANG
;
Xiaojun YANG
Author Information
1. Department of Transfusion, Zhongshan Hospital Affiliated to Xiamen University, Xiamen, Fujian 361003, China. 425659271@qq.com.
- Publication Type:Journal Article
- MeSH:
Humans;
ABO Blood-Group System/genetics*;
Pedigree;
East Asian People;
Genotype;
Phenotype;
Alleles;
Glycosyltransferases/genetics*;
Molecular Biology
- From:
Chinese Journal of Medical Genetics
2023;40(6):750-755
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the serological characteristics of ABO blood group and molecular genetic mechanism for a Chinese pedigree with cisAB09 subtype.
METHODS:A pedigree undergoing ABO blood group examination at the Department of Transfusion, Zhongshan Hospital Affiliated to Xiamen University on February 2, 2022 was selected as the study subjects. Serological assay was carried out to determine the ABO blood group of the proband and his family members. Activities of A and B glycosyltransferases in the plasma of the proband and his mother were measured with an enzymatic assay. Expression of A and B antigens on the red blood cells of the proband was analyzed by flow cytometry. Peripheral blood samples of the proband and his family members were collected. Following extraction of genomic DNA, exons 1 to 7 of the ABO gene and their flanking introns were sequenced, and Sanger sequencing of exon 7 was carried out for the proband, his elder daughter and mother.
RESULTS:The results of serological assay suggested that the proband and his elder daughter and mother had an A2B phenotype, whilst his wife and younger daughter had an O phenotype. Measurement of plasma A and B glycosyltransferase activity suggested that the titers of B-glycosyltransferase activity were 32 and 256 for the proband and his mother, which were respectively below and above that of A1B phenotype-positive controls (128). Flow cytometry analysis showed that the expression of A antigen on the red blood cell surface of the proband has decreased, whilst the expression of B antigen was normal. Genetic sequencing confirmed that, in addition to an ABO*B.01 allele, the proband, his elder daughter and mother have harbored a c.796A>G variant in exon 7, which has resulted in substitution of the methionine at 266th position of the B-glycosyltransferase by valine and conformed to the characteristics of ABO*cisAB.09 allele. The genotypes of the proband and his elder daughter were determined as ABO*cisAB.09/ABO*O.01.01, his mother was ABO*cisAB.09/ABO*B.01, and his wife and younger daughter were ABO*O.01.01/ABO*O.01.01.
CONCLUSION:The c.796A>G variant of the ABO*B.01 allele has resulted in an amino acid substitution p.Met266Val, which probably underlay the cisAB09 subtype. The ABO*cisA B.09 allele encodes a special glycosyltransferase which can synthesize normal level of B antigen and low level of A antigen on the red blood cells.
